We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

IPR: A 2nd Bite At The Apple For Hatch-Waxman Litigants

Law360, New York (March 11, 2014, 6:36 PM EDT) -- With the advent of inter partes review, Congress authorized a second and parallel adjudicatory proceeding for generic pharmaceutical companies to challenge the validity of Orange Book-listed patents.[1] The first option, of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.